Company Name: Alcobra Ltd.

Alcobra Ltd. is a biopharmaceutical company. The company’s focus is on developing and commercializing its MDX product candidate for cognitive disorders including:

  • Attention Deficit Hyperactivity Disorder (ADHD)
  • Fragile X Syndrome

Ticker Symbol: ADHD (NASDAQ)

Company Website: www.alcobra-pharma.com

Headquarters: Tel Aviv, Israel